News Headline Summary

Watson Pharmaceuticals (WPI) says generic Lysteda receives FDA approval and intends to begin shipping the product immediately

03 Jan 2013 - 14:01 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: